Chardan医疗保健收购 PHGE 深 沪
已收盘 02-06 16:00:00 美东时间
3.93
-0.630
-13.82%
华盛通- 最 高4.77
- 今 开4.71
- 成交量 6.21万股
- 最 低 3.93
- 昨 收 4.56
- 总市值 599.97万
- 52周最高 22.0571
- 市盈率 静 --
- 换手率 4.07%
- 52周最低 1.5004
- 委 比 0.00%
- 总股本 152.66万
- 历史最高 2261.00
- 量 比 0.48
- 振 幅 18.42%
- 历史最低 1.87
- 每 手 1
- 风险率 3.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多What's Driving the Market Sentiment Around BiomX Inc?
BiomX Inc's (NYSE:PHGE) short interest as a percent of float has fallen 17.53% ...
01-29 01:00
BRIEF-BiomX Says Unaware of Any Undisclosed Developments Amid Unusual Stock Trading
BRIEF-BiomX Says Unaware of Any Undisclosed Developments Amid Unusual Stock Trading Jan 27 (Reuters) - BiomX Inc PHGE.A : BIOMX ISSUES STATEMENT REGARDING RECENT COMMON STOCK TRADING ACTIVITY BIOMX INC - NOT AWARE OF UNDISCLOSED MATERIAL DEVELOPMENTS Source text: ID:nGNXYFgS5 Further company coverag
01-28 02:49
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Nuwellis (NASDAQ:NUWE) shares rose 81.5% to $3.9 during Tuesday's regu...
01-28 01:05
Market-Moving News for January 27th
JBLU: -7% | JetBlue Airways shares are trading lower after the company reported worse-than-expected Q4 EPS. PHGE: 165% | BiomX shares are trading higher after a 13D filing disclosed that Pyu Pyu Capital
01-27 20:19
BiomX Issues Statement Regarding Recent Common Stock Trading Activity
BiomX Inc. issued a statement addressing recent unusual market activity in its common stock. The company stated that it is unaware of any undeclared material developments or reasons for the market activity. NYSE American LLC requested this statement as part of its standard procedure, and the company intends to refrain from commenting on market speculation or trading activity. BiomX specializes in developing phage therapies targeting harmful bacte...
01-27 18:41
Why Biomx Shares Are Trading Higher By Over 100%; Here Are 20 Stocks Moving Premarket
Shares of Biomx Inc (NYSE:PHGE) rose sharply in pre-market trading after a 13D ...
01-27 17:51
BiomX Announces New Preferred Stock Financing and Warrants
BiomX ( ($PHGE) ) just unveiled an announcement. On December 26, 2025, BiomX In...
2025-12-30 06:47
BiomX Commences ~$3M Private Placement Of Series Y Convertible Preferred Stock
BiomX Inc. (NYSE American: PHGE) ("BiomX" or the "Company"), a clinical-stage company advancing novel natural and engineered phage therapies targeting specific pathogenic bacteria, today announced that it has entered
2025-12-29 21:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Adlai Nortye (NASDAQ:ANL) stock moved upwards by 44.5% to $2.37 during...
2025-12-29 20:05
BiomX Announces $3.0 Million Private Placement
BiomX Inc. has completed a $3.0 million private placement, issuing Series Y Convertible Preferred Stock with warrants, yielding 15% annual dividends. Proceeds support the evaluation of its phage therapy programs, including BX011 for Staphylococcus aureus infections, and strategic alternatives.
2025-12-29 13:00
